Coya Therapeutics, Inc. Common Stock

COYANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
3.95 USD
↗ 0.01 (0.25%)AT CLOSE (03:59 PM EDT)
4.00
↗ 0.05 (1.34%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
4.00
↗ 0.05 (1.34%)
🔴Market: CLOSED

Coya Therapeutics, Inc. Common Stock (COYA) is currently trading at $3.95. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. COYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 26, 2026.

Open?$3.95
High?$4.03
Low?$3.91
Prev. Close?$3.94
Volume?129.6K
Avg. Volume?150.9K
VWAP?$3.95
Rel. Volume?0.86x
Bid / Ask
Bid?$3.90 × 100
Ask?$4.08 × 100
Spread?$0.18
Midpoint?$3.99
Valuation & Ratios
Market Cap?92.7M
Shares Out?23.5M
Float?17.5M
Float %?74.5%
P/E Ratio?N/A
P/B Ratio?2.14
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Immunology & Autoimmune
Employees
8
Market Cap
92.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.coyatherapeutics.com
Listed
2022-12-29
Address
12645 MEMORIAL DR., SUITE F1 #305
HOUSTON, TX 77024
Phone: 650.739.3939
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
65
Short Sent.?
49
Piotroski F-Score?2/9Weak
Altman Z-Score?11.17Safe
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.18%Elevated
Short Interest?1.3M
Days to Cover?8.6
Free Float17.5M
Avg Daily Volume145.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?13.40Strong
Quick Ratio?13.40Strong
Cash Ratio?12.29Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.14CHEAP▾
P/S?
Peers
100
S&P
6
11.55HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.1CHEAP▾
EV/Sales?
Peers
100
S&P
26
6.17HIGH▾
Returns & Efficiency
ROE?
S&P
3
-50.1%WEAK▾
ROA?
S&P
3
-45.8%WEAK▾
Cash Flow & Enterprise
FCF?$-15722176
Enterprise Value?$49.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist